TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis A Xu, L Zhang, J Yuan, F Babikr, A Freywald, R Chibbar, M Moser, ... Cellular & Molecular Immunology 16 (10), 820-832, 2019 | 44 | 2019 |